Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription

Journal of Biomolecular Screening

Volumn 6, Issue 2, 2001, Pages 101-110

  Subbaramaiah, Kotha ^a   Bulic, Predrag ^b   Lin, Yuan ^c   Dannenberg, Andrew J ^a   Pasco, David S ^d  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c Marco Polo Technologies   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARNEBIA EUCHROMA EXTRACT; CYCLOOXYGENASE 2 INHIBITOR; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; SHIKONIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SCREENING; ENZYME ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEDICINAL PLANT; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; REPORTER GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; ISOENZYMES; LUCIFERASES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHOQUINONES; PLANT EXTRACTS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ARNEBIA; ARNEBIA EUCHROMA;

EID: 0035032366     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1089/108705701750160282     Document Type: Article

References (68)

1. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
2. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
3. Benzo(a)pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
4. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
5. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester
6. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells
7. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells
8. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element
9. Dihydroxy bile acids activate the transcription of cyclooxygenase-2
10. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
11. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effects
12. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
13. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
14. Expression of cyclooxygenase-2 in human gastric carcinoma
15. Cyclooxygenase-2 gene expression in human breast cancer
16. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
17. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
18. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis
19. Expression of cyclooxygenase-2 in human lung carcinoma
20. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
21. Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin
22. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
23. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
24. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor
25. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl)nitrosamine
26. Prostaglandins, their inhibitors and cancer
27. Prostaglandins in squamous cell carcinoma of the head and neck: A preliminary study
28. Altered eicosanoid levels in human colon cancer
29. 2 in human colon cancer cells
30. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
31. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation in interleukin 10 and down-regulation of interleukin 12 production
32. Regulation of the immune response by prostaglandins
33. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
34. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
35. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation
36. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells
37. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
38. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages
39. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene
40. Protein measurement with the Folin phenol reagent
41. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
42. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
43. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells: Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element
44. Ceramide regulates the transcription of cyclooxygenase-2: Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways
45. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2
46. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10
47. A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene
48. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2
49. New napthoquinone derivatives from Lithospermum erythrorhizon
50. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells
51. Benzópyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells
52. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells
53. Selective inhibition of cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic
54. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis
55. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
56. Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats
57. Antitumor activity of shikonin and its derivatives
58. A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin
59. Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro
60. Shikonin, an ingredient of Lithospermum erythrorhizon, induced apoptosis in HL60 human promyelocytic leukemia cell line
61. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis
62. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
63. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
64. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells
65. Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane)
66. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells
67. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein
68. Overexpression of cyclooxygenase-2 induces cell cycle arrest